Revolutions Medical Corp. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2009
2010
2011
2012
2013
Sales/Revenue
-
-
-
1.20
41.40
Cost of Goods Sold (COGS) incl. D&A
3.50
6.00
17.00
895.80
117.80
Gross Income
3.50
6.00
17.00
894.60
76.40
SG&A Expense
844.70
2,366.90
3,838.30
4,081.60
3,800.40
EBIT
848.20
2,373.00
-
4,976.20
3,876.80
Unusual Expense
163.30
-
119.10
733.70
1,694.70
Non Operating Income/Expense
1,452.20
-
-
273.10
0.80
Interest Expense
-
8.50
567.10
1,727.50
852.30
Pretax Income
2,463.80
2,381.40
4,541.50
7,164.30
6,424.50
Consolidated Net Income
2,463.80
2,381.40
4,541.50
7,164.30
6,424.50
Net Income
2,463.80
2,381.40
4,541.50
7,164.30
6,424.50
Net Income After Extraordinaries
2,463.80
2,381.40
4,541.50
7,164.30
6,424.50
Net Income Available to Common
2,463.80
2,381.40
4,541.50
7,164.30
6,424.50
EPS (Basic)
0.08
0.06
0.09
0.12
0.07
Basic Shares Outstanding
31,848.20
36,762.00
49,149.10
61,779.80
91,264.30
EPS (Diluted)
0.08
0.06
0.09
0.12
0.07
Diluted Shares Outstanding
31,848.20
36,762.00
49,149.10
61,779.80
91,264.30
EBITDA
844.70
2,366.90
3,838.30
4,873.20
3,778.80
Non-Operating Interest Income
-
-
0.00
-
-
About Revolutions Medical
View Profile
